Currently out of the existing stock ratings of Kerry Holford, 6 are a HOLD (35.29%), 11 are a BUY (64.71%).

Kerry Holford

Work Performance Price Targets & Ratings Chart

Analyst Kerry Holford works at BERENBERG with a stock forecast success ratio of 50% fulfilled within 107.75 days on average. Previously, Kerry Holford worked at BNP.

Kerry Holford’s has documented 32 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 20-Jun-2023.

Wall Street Analyst Kerry Holford

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 10/11/2021. The price target of $270 was fulfilled within 66 days with a profit of $42.44 (18.65%) receiving and performance score of 2.83.

Average potential price target upside

GSK GlaxoSmithKline PLC ADR LLY Eli Lilly and Company NVS Novartis AG ADR NVO Novo Nordisk A/S

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

44

$2.1 (5.01%)

1 months 7 days ago

0/9 (0%)

$4.72 (12.02%)

Buy

22.87

1 months 14 days ago

0/11 (0%)

$-19.77 (-46.36%)

Hold

48

$6.1 (14.56%)

1 months 27 days ago

1/4 (25%)

$9.08 (23.33%)

261

Sell

17.1

7 months ago

0/10 (0%)

$-16.67 (-49.36%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Kerry Holford?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?